Why Did Nirman Agri Genetics Shares Plummet After SEBI's IPO Fund Misuse Ban?
Click to start listening
Synopsis
Nirman Agri Genetics Limited faces severe scrutiny as SEBI halts its market activities over allegations of IPO fund misuse. This ban leads to a significant drop in share prices, raising questions about the company's financial practices and transparency.
Key Takeaways
- Nirman Agri Genetics shares fell sharply after SEBI's intervention.
- SEBI's investigation revealed significant fund misappropriation.
- Corporate actions like bonuses and name changes are halted.
- Promoter Pranav Kailas Bagal faces trading restrictions.
- Serious concerns about the company's financial transparency.
Mumbai, Oct 15 (NationPress) Shares of Nirman Agri Genetics Limited (NAGL), which is listed as an SME, experienced a significant decline, hitting the 5 percent lower circuit on Wednesday. This drop occurred following a decision by the Securities and Exchange Board of India (SEBI) to prohibit the company from engaging in the securities market due to allegations of misuse of IPO funds.
In its interim ruling, SEBI mandated that the company halt all planned corporate activities, including a proposed bonus issuance, stock split, and its intended rebranding to ‘Agriicare Life Corp Limited’, until further notice.
As of October 15, NAGL's shares fell by 5 percent, reaching Rs 166.85 per share. The stock has a 52-week low of Rs 130 and a 52-week high of Rs 456, with the company’s market capitalization estimated at around Rs 133 crore.
SEBI’s directive was issued by Whole-Time Member Kamlesh Chandra Varshney, who also barred the company’s promoter, Pranav Kailas Bagal, from any trading activity involving NAGL shares—either directly or indirectly—until further instructions are provided.
The investigation by the market regulator indicated that NAGL had misappropriated approximately Rs 18.89 crore, which is nearly 93 percent of its total IPO proceeds of Rs 20.30 crore.
The funds were reportedly allocated to entities deemed to be fraudulent, dubious, or under the control of Bagal and his family members.
According to SEBI, NAGL provided inconsistent and untrustworthy information about the deployment of IPO funds and failed to present substantial evidence to back its assertions.
The regulator highlighted that the company did not supply authentic agreements or invoices corresponding to payments totaling Rs 12.14 crore to four vendor entities.
Furthermore, the order revealed that several bank accounts receiving these payments were actually associated with unrelated third parties.
During inspections, the National Stock Exchange (NSE) discovered that the entities listed by NAGL did not exist at the addresses given, and no agricultural activities were observed there.
SEBI concluded that the company's actions raised significant concerns regarding fund diversion and false disclosures, stating that the imposed restrictions will remain until the investigation is resolved.
Point of View
It's crucial to provide an unbiased analysis of the Nirman Agri Genetics situation. The recent actions by SEBI highlight serious concerns regarding corporate governance and transparency within the company. Investors must remain vigilant and informed as this story unfolds, ensuring accountability and trust in the financial markets.
NationPress
15/10/2025
Frequently Asked Questions
What caused the drop in Nirman Agri Genetics shares?
The shares plummeted after SEBI barred the company from the securities market due to alleged misuse of IPO funds.
What actions did SEBI take against Nirman Agri Genetics?
SEBI prohibited the company from undertaking any corporate actions and restricted the promoter from trading NAGL shares.
How much of the IPO funds were misused?
Approximately Rs 18.89 crore, nearly 93 percent of the total IPO proceeds, were allegedly misappropriated.
What were the findings of SEBI's investigation?
SEBI found that NAGL provided conflicting information and failed to substantiate its claims about the use of IPO funds.
What is the current status of Nirman Agri Genetics?
The company is under restrictions until further notice from SEBI, pending further investigation.
